🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Centralization and Oncologic Outcomes in Ovarian Cancer

Recruitingn/aAges 18 Years - 99 YearsFemaleAzienda USL Reggio Emilia - IRCCS
NCT07075939 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a multicenter, observational, retrospective and prospective study conducted within the REMO (Reggio Emilia - Modena) network in the Emilia-Romagna region (Italy), promoted by AUSL-IRCCS of Reggio Emilia. The study aims to evaluate the impact of surgical centralization and treatment strategies adopted during the COVID-19 pandemic on oncologic outcomes in patients diagnosed with the epithelial ovarian cancer (EOC) from 2018 to 2023. The retrospective component includes patients treated between 2018 and 2023, while the prospective component consists of clinical follow-up of those patients over the next five years.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Female patients aged between 18 and 99 years * Histological and/or cytological diagnosis of epithelial ovarian cancer * Patients evaluated by the Multidisciplinary Tumor Board (MTB) of the AUSL-IRCCS of Reggio Emilia * Patients treated between January 1, 2018, and December 31, 2023 * Availability of clinical records and outcome data * Signed informed consent where possible, in accordance with GDPR and Italian regulations Exclusion Criteria: * Patients without histological or cytological confirmation of epithelial ovarian cancer * Incomplete or missing data for key clinical indicators * Patients unable to provide informed consent and for whom recontact is not possible * Patients deemed unable to understand and provide consent (e.g., severe cognitive impairment)
💊

What it tests

  • No Intervention: Observational Cohort
📍

Where

7 sites
Azienda Unità - Sanitaria locale di Modena - Ospedale Razzini Carpi
Carpi, Italy
Azienda Unità - Sanitaria locale di Modena - Ospedale di Mirandola
Mirandola, Italy
Azienda Unità - Sanitaria locale di Modena - Ospedale Pavullo nel Frignano
Pavullo nel Frignano, Italy
Azienda Unità - Sanitaria locale di Modena - Ospedale Civile Sassuolo
Sassuolo, Italy
Azienda Unità - Sanitaria locale di Modena - Ospedale di Vignola
Vignola, Italy
Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, Italy
Azienda Ospedaliero - Universitario di Modena
Modena, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy